THE NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN, LEUCINE RICH REPEAT CONTAINING X1 (NLRX1) AGONIST NX-13 DEMONSTRATES RAPID SYMPTOMATIC AND BIOMARKERS IMPROVEMENT IN ULCERATIVE COLITIS: RESULTS IN A PHASE 1B STUDY

Jean-Frédéric Colombel  ¹     Laurent Peyrin-Biroulet  ²     Brian G. Feagan  ³     Andres Yarur  ⁴     Remo Panaccione  ⁵     Simon Lichtgier  ⁶     Rebecca Mosig  ⁶     Fabio Cataldi  ⁶     Marla C. Dubinsky  ^7    
1 Icahn School of Medicine at Mount Sinai, USA, United States
² Nancy University Hospital, Vandoeuvre-les-Nancy, France
³ The University of Western Ontario, London, Canada
⁴ Cedars-Sinai Medical Center, Los Angeles, United States
⁵ University of Calgary, Calgary, Canada
⁶ Landos Biopharma, Inc, Blacksburg, United States
⁷ Mount Sinai Hospital, Mount Sinai, New York City, United States

Topic
Endoscopy, Histopathology, IBD

Session
The new kids on the block for IBD: Part 1

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)